SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is trending amidst fervent community debate over its immediate direction, with bulls pointing to strong on-chain activity, like surging daily transactions and declining gas fees, alongside bullish chart patterns signaling a potential breakout. However, bearish sentiment persists, fueled by broader market volatility and uncertainty surrounding the delayed Digital Asset Market Clarity Act and recent geopolitical tariff discussions. The intense back-and-forth reflects a market seeking conviction on whether the current price action represents a healthy pullback or a precursor to further declines.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending amid intense community discussion focused on global trade tensions, including renewed tariff talks, and broader market uncertainty driving recent volatility. Many users are debating whether this presents a "buy the dip" opportunity while others express concern over perceived market manipulation and Bitcoin's challenged "safe haven" narrative.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPDR S&P 500 ETF Trust (SPY) is trending as investors grapple with escalating geopolitical tensions stemming from recent tariff threats against Europe concerning Greenland. While some predict a significant market downturn, citing red futures and potential economic disruption, others anticipate a quick recovery, referencing past instances where such threats were walked back. The community is actively debating the market's direction, with discussions highlighting both caution and the expectation of a 'buy the dip' opportunity after the extended holiday.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

Anavex Life Sciences is actively trending amid its pursuit of re-examination with the European Medicines Agency for blarcamesine and recent engagement with the U.S. FDA, which has requested full clinical data for a potential New Drug Application. The community is highly focused on these regulatory advancements, alongside the company's strategic participation in the European Commission's ACCESS-AD initiative and a key senior leadership hire, as potential catalysts for its precision medicine Alzheimer's treatment. These developments underscore the growing demand for safe, oral therapies in a landscape seeking alternatives to current options.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending following its recent Vision AI showcase, expanding its multimodal capabilities in conversational AI. The company's innovative technology, substantial revenue backlog, and zero-debt balance sheet are driving bullish sentiment and attracting renewed analyst optimism for significant long-term growth. However, community discussion reflects a divided view, with some expressing frustration over persistent market manipulation and high short interest impacting its near-term price action, especially as crucial earnings approach.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending amidst escalating global trade tensions, driven by new US tariff threats against European nations regarding Greenland and reports of potential EU retaliatory measures. Community discussions are sharply divided between anticipating a significant market pullback for the tech-heavy Nasdaq and a belief that historical "buy the dip" patterns will prevail, especially with a Supreme Court ruling on tariffs keenly awaited.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Dexcom Inc

Dexcom is seeing high conversation volume following an FDA Class 1 recall for its G7 receivers over potential alert failures, intensifying community debate around product reliability and ongoing lawsuits. This comes as shares reacted cautiously despite stronger-than-expected preliminary Q4 revenue, leading many to question its valuation and market share amidst competitors. However, recent FDA clearance for Dexcom Smart Basal offers a positive signal regarding future innovation in diabetes management.

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is trending as investors debate the potential value unlocked by its planned two-company spin-off by 2026 and the arrival of new CEO, Steve Cahillane. While many see it as a deeply undervalued "safety stock" with a strong dividend, particularly as a defensive play during market rotation, others remain skeptical about the processed food sector's future and accuse recent analyst downgrades of being manipulative.

United States Commodity Funds LLC - United States Natural Gas Fund

United States Natural Gas Fund, LP

United States Natural Gas Fund (UNG) is trending sharply higher, fueled by forecasts for colder weather and a growing narrative around increased demand from AI data centers. The community is actively discussing potential short squeezes and significant gains, recognizing natural gas as a volatile yet crucial energy source for future technological infrastructure.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is generating substantial buzz driven by positive clinical data from its pancreatic cancer study, highlighting an immune-preserving "abscopal effect." Community conversation centers on the imminent anticipation of regulatory approval in Japan and a recent presentation at a major healthcare conference. This widespread discussion underscores excitement for its revolutionary alpha-radiation technology and growing institutional visibility.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of "Hold" by Analysts

Journey Medical Corporation (NASDAQ:DERM - Get Free Report) has been assigned an average rating of "Hold" from the five ratings firms that are currently covering the company, MarketBeat.com reports...

Journey Medical Corporation (NASDAQ:DERM) Receives Average Recommendation of "Hold" from Analysts

Journey Medical Corporation (NASDAQ:DERM - Get Free Report) has been given an average rating of "Hold" by the five brokerages that are currently covering the company, MarketBeat.com reports. One...

Sheets Smith Investment Management Invests $946,000 in Journey Medical Corporation $DERM

Sheets Smith Investment Management acquired a new position in shares of Journey Medical Corporation (NASDAQ:DERM - Free Report) during the 3rd quarter, according to the company in its most recent...

Journey Medical (NASDAQ:DERM) Trading 2.1% Higher - What's Next?

Journey Medical (NASDAQ:DERM) Trading 2.1% Higher - Time to Buy...

Journey Medical Corporation (NASDAQ:DERM - Get Free Report) has earned a consensus recommendation of "Hold" from the five brokerages that are presently covering the firm, Marketbeat Ratings reports...

FY2025 EPS Forecast for Journey Medical Decreased by Analyst

Journey Medical Corporation (NASDAQ:DERM - Free Report) - Equities research analysts at HC Wainwright cut their FY2025 EPS estimates for shares of Journey Medical in a report released on Thursday...

B. Riley Increases Earnings Estimates for Journey Medical

Journey Medical Corporation (NASDAQ:DERM - Free Report) - Analysts at B. Riley raised their FY2029 earnings per share (EPS) estimates for Journey Medical in a report issued on Thursday, November...

HC Wainwright Forecasts Weaker Earnings for Journey Medical

Journey Medical Corporation (NASDAQ:DERM - Free Report) - Research analysts at HC Wainwright cut their FY2026 earnings estimates for Journey Medical in a research report issued to clients and...

Journey Medical (NASDAQ:DERM) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Journey Medical (NASDAQ:DERM - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.05) by...

Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Journey Medical (DERM) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.05	--	--	N/A
Q3 '25	-$0.05	-$0.09	-89.47%	MISSED
Q2 '25	-$0.10	-$0.16	-52.38%	MISSED
Q1 '25	-$0.24	-$0.18	24.21%	BEAT
Q4 '24	-$0.20	$0.10	150.63%	BEAT

DERM
Journey Medical Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest DERM News

DERMJourney Medical Corp